Digital From R&D to ROI: AI’s impact on pharma commercialisation AI in pharma commercialisation is transforming patient and healthcare provider engagement, streamlining regulatory reviews, and developing hyper-informed treatment pricing models, despite current scaling challenges.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
